Summary. Vascular responsiveness to vasoactive eicosanoids as well as vascular prostacyclin and thromboxane production was investigated in %10 weeks alloxan-diabetic rats. Aortic rings from diabetic rats exhibited increased responsiveness to carbocyclic thromboxane A2, a thromboxane analogue, when compared to control rat aortae. Isolated perfused hearts of diabetic rats showed increased vascular responsiveness to 9,11-methanoepoxy PGH2 (U-46619), an endoperoxide analogue. Diabetes resulted in a reduction in prostacyclin generation by isolated incubated aortae which was overcome by the addition of arachidonic acid but not by homogenization of incubated aortic tissue. In contrast, prostacyclin, but not thromboxane, generation was elevated in isolated perfused hearts of diabetic animals in response to moderate doses of arachidonic acid, but at high doses of arachidonate, more thromboxane was formed by perfused hearts of diabetic rats. These results suggest that different vessels can either increase or decrease their prostaglandin production in response to diabetes. The alterations in prostanoid production may be due to differential changes in prostacyclin and thromboxane synthesis in vessels which, in turn, may be related to the changes in vascular responsiveness.
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Vascular integrity is profoundly altered in diabetic animals during the progression of diabetes. Some of these changes may be related to the ability of the blood vessel wall to synthesize and release vasoactive prostanoids [11] . In this regard, vascular tissue from diabetic animals was shown to produce less of the vasodilator prostanoid, prostacyclin (PGI2) [1, 17, 21] , a substance that also prevents platelet aggregation [4] and stabilizes lysosomal membranes [9] . Others have reported, however, an enhanced generation of PGI2 by the coronary vasculature of diabetic rats [181. Very little is known about the ability of vessels from diabetic animals to generate thromboxane A2 (TxA2), a potent vasoconstrictor, inducer of platelet aggregation and labilizer of lysosomal membranes [5] . Thromboxane A2 is produced largely by platelets [19] , but also is generated by blood vessels and myocardial cells [7] . In this regard, platelets from diabetic patients produce more TxA2 than those from normal subjects [4, 8] .
Another important aspect of altered vascular homeostasis in diabetes is responsiveness to endogenous vasoactive humoral substances. In this regard, blood vessels of diabetic animals are reported to be hyperresponsive to vasoconstrictor prostanoids and hyporesponsive to vasodilator prostanoids [13, 23] . Whether any relationship exists between the ability of the blood vessel to generate vasoactive prostanoids and its vasoactive sensitivity to these agents (e. g. PGI2 and TxA2) remains to be determined.
The major purposes of this study were (a) to define the ability of large arteries (e. g. aorta) and of the coronary vasculature of diabetic animals to generate PGI2 and TxA> and (b) to relate these findings to the responsiveness of arterial vessels to PGI2 and to chemically stable endoperoxide and thromboxane analogues.
Methods

Induction of Diabetes
Diabetes was induced in male Sprague-Dawley rats (weight 225-250 g) by intravenous injection of alloxan at a dose of 45 mg/kg body weight. Diabetic animals were used 7-10weeks later. Weightmatched non-diabetic animals were used as controls. Before sacrifice, glucosuria was confirmed in diabetic rats with Ketodiastix (Miles Laboratory, Elkhart, Indiana, USA). Blood collected at the time of experimentation was used for serum glucose determinations by a glucose oxidase method [16] . Serum glucose averaged 8.9+0.3 and 25.1 • 1.0 mmol/1 (mean +_+_ SEM) for control and diabetic rats, respectively.
Cardiac Perfusion
Hearts were quickly excised and abdominal and thoracic aortae removed from pentobarbital-anaesthetized rats. All hearts were perfused by the Langendorff procedure for an initial 10 min at an aortic pressure of 60mmHg. Hearts were then perfused retrogradely through the aorta at a constant flow of 14-16 ml/min while they were electrically paced at a rate of 300 beats/rain. The perfusate employed was Krebs-Henseleit bicarbonate solution containing 11 mmol/1 glucose at pH 7.35, and maintained at 37 _+ 0.2 ~ equilibrated with 95% O2 + 5% CO2. The perfusate was not recirculated at any time. Coronary perfusion pressure was monitored continuously throughout all experiments from a side-ann in the aortic inflow tract, connected to a Statham P-23 pressure transducer (Statham Medical Instruments, Hato Rey, Puerto Rico) and recorded on a Grass Model 7 oscillographic recorder (Grass Instruments, Quincy, Massachusetts, USA).
Vascular Responsiveness
Thoracic aortae were trimmed of excess fat and connective tissue and cut into tings approximately 4mm in length. The rings were suspended from a Statham FT-03 force transducer (Statham Medical Instruments) and secured using two stainless steel hooks and silk. The tings were suspended in 20 ml water jacketed baths containing oxygenated Krebs-Henseleit solution maintained at 37+0.2~ Rings were preloaded with 1 g force and allowed to equilibrate for 2 h before adding any humoral agent. The Krebs-Henseleit solution was changed every 20-30 min during the incubation. Following the experiment, the cross-sectional area of the rings was measured, and the tissue was then dried for 24 h in order to obtain dry weight values.
Eicosanoid Measurements
Segments of abdominal aortae were preincubated in Krebs-Henseleit buffer (1 ml) at 20 ~ for 2 h to remove substances formed during the removal of the vessel. The vessels were then weighed, placed in Krebs-Henseleit buffer (0.1 ml/1 mg tissue) and incubated in a metabolic shaker bath at 37 ~ for 10 rain. Aliquots (250 ~1) of buffer were sampled at 0, 2.5, 5, 7.5 and 10 min. Arachidonic acid (80 umol/l) in I mmol/1 sodium bicarbonate was added to some vessels for a 10-rain incubation period. Following incubation, some vessels were suspended in Krebs-Henseleit solution (0.2 ml/mg tissue) and homogenized using a Brinkman Polytron homogenizer (New York, USA) at a setting of 10 for two 10-s bursts. After homogenization, aliquots (250 !-tl) of the homogenate were removed for 6-keto-PGFa~ analysis. The concentration of 6-keto-PGFa~ (i. e. the stable breakdown product of prostacyclin) was determined in vessel homogenates and incubation buffers, as well as in coronary effluents using a specific radioimmunoassay according to previously established methods [7] . TxBz, the stable breakdown product of TxA2, was also measured in coronary effluents using a specific radioimmunoassay according to the method of Lewy et al. [10] .
Statistical evaluations of the data were performed using Student's t-test for unpaired comparisons.
Results
Body and heart weights of diabetic and weight-matched control rats were recorded and analyzed. No significant differences were observed in heart weights of diabetic animals when compared with weight-matched controls, nor were there any changes in dry weight to wet weight ratios of hearts from control or diabetic rats. In preliminary studies, no significant differences were observed between age-matched and weight-matched control animals. 
Vascular Reactivity
Vascular reactivity of diabetic rat aortic smooth muscle exhibited an increased sensitivity to thromboxane-like substances. There was a significantly increased constrictor response to the TxA2 analogue, carbocyclic TxA2 at 100nmol/1 (p<0.05) in aortic rings isolated from diabetic rats. The amount of force generated in diabetic vessels was 1060 + 187 mg compared with 603 _ 74 mg force for control aortic rings (p < 0.05). This same trend of increased constrictor responsiveness was observed also with the endoperoxide analogue (U-46619) at 100 nmol/1, although it was not statistically significant. The same differences were observed even after normalization of values using the cross sectional area or tissue dry weight; however, prostacyclin at 50 and 100nmol/1 failed to dilate the aortic ring preparation in vessels from either control or diabetic rats. The calcium channel blocker, nifedipine (50 ng/ml, Pfizer Laboratories, New York, USA) was able to relax completely (i, e. 95%-100%) the preparation in the presence of 100 nmol/1 carbocyclic thromboxane A> Vascular responsiveness was studied also in the coronary circulation of diabetic and control rats. Before studying the effect of diabetes on vascular responsiveness to prostaglandin analogues in isolated perfused hearts, however, it was necessary to determine whether diabetes altered the passive resistance of the coronary vasculature. Therefore, the relationship between coronary flow and coronary perfusion pressure was studied in isolated perfused hearts of both control and diabetic animals. Figure 1 shows that changes in coronary flow were associated with changes in coronary perfusion pressure of a comparable magnitude in hearts from control and diabetic rats. Thus, no measurable alteration in the passive resistance of the coronary vasculature occurred 7-10weeks after the induction of diabetes. Hence, the change in the vascular responsiveness to U-46619 found in hearts of diabetic animals ( Fig. 2) is even more striking. Vessels of control and diabetic hearts responded to the same threshold dose of U-46619. However, at higher doses of U-46619, diabetic vessels exhibited up to twice the constrictor response of the controls. Moreover, diabetic hearts tended to develop arrhythmias when perfusion pressure exceeded 160 mmHg. Approximately 50% of these hearts subsequently went into a contracture state associated with a very rapid and large increase in perfusion pressure. Therefore, the vascular response to U-46619 reported in these hearts was based on coronary perfusion pressure prior to contracture. The contracture and elevated perfusion pressure could be reversed by nifedipine (100 ng/ml). The increased responsiveness of the vasculature of diabetic hearts to U-46619 did not appear to be due to a non-specific increase in responsiveness to constrictor agents, since increased reactivity to 10-Smol/1 serotonin was not observed (perfusion pressure of 25 + 4 and 30 + 4 mmHg for hearts from control and diabetic rats, respectively) under the same experimental conditions.
Eicosanoid Generation
Prostacyclin generation was originally studied in both the abdominal and thoracic aorta where a significant decrease in prostacyclin production was observed in both thoracic and abdominal aortas from diabetic rats (p < 0.01). Subsequent studies were carded out using the release by abdominal aortae from diabetic ( 9 ..... 9 and control rats (O---C)) following addition of arachidonic acid (80 txmol/1) at time 0. Values represent mean_+ SEM for four pairs of vessels abdominal aorta since this proved to have a more consistent response. Prostacyclin generation over a 7.5 rain incubation period was significantly reduced in the abdominal aorta of the diabetic rat. Figure 3 displays the time course of this prostacyclin generation. Thus, a significantly reduced prostacyclin generation occurred at 5 min, with maximal decreases at 7.5 and 10 min. The reduction in prostacyclin generation could be abolished by addition of arachidonic acid (80 ~imol/1) to the incubation medium. Figure 4 shows that arachidonic acid actually elevated the reduced PGI2 values in diabetic vessels, suggesting a substrate limiting factor during diabetes. In this regard, homogenates of the abdominal aortae from diabetic rats also showed a significantly decreased amount of prostacyclin compared with control rats (6.5+2.4 versus 13.7+1.7pmol/ml, p<0.05; Fig. 5 ). Thus, compartmentalization of substrate and enzyme is not the explanation for the difference in PGI2 production between control and diabetic rat vessels. All values represent mean_+ SEM for seven to eight values in each group. Hearts were perfused through the aorta at a constant flow of 14-16 ml/min with Krebs-Henseleit buffer. Following an initial 15-rain equilibration period, arachidonic acid was injected at 15-rain intervals into the aortic inflow tract. Coronary effluent was collected for 20 s following each injection and assayed for 6-keto-PGFl~ and TxB~ concentration
The effect of diabetes on PGI2 and TxB2 production by perfused hearts is shown in Table 1 . No basal release of either PGI2 or TxB2 could be detected from either control or diabetic hearts. However with the addition of 30 ~g of arachidonic acid, PGI2 could be detected in coronary effluents. PGI2 release was found to be two to three times higher in hearts of diabetic animals compared with hearts from control rats at this moderate dose of arachidonic acid used. At higher doses of arachidonic acid (i. e 120 .ug), there was a significant increase in the concentration of TxB2 generated, but not in that of 6-keto PGFt~ in diabetic hearts. Thus, at high arachidonic acid doses, diabetic hearts shift toward greater thromboxane production than control hearts.
Discussion
The present studies demonstrate that both the aorta and coronary vessels of diabetic animals show increased responsiveness to prostanoid vasoconstrictors (i. e thromboxane and endoperoxide analogues). In this connection, aortic tings of diabetic animals showed significantly increased responsiveness to carbocyclic thromboxane A2, a thromboxane analogue, and a tendency towards increased responsiveness to 9,11-methanoepoxy PGH2, an endoperoxide analogue. These findings are consistent with earlier studies on the responsiveness of isolated aortic preparations from diabetic animals, in which an increased responsiveness to non-prostanoid vasoconstrictors, such as noradrenaline, angiotensin, potassium chloride and calcium chloride were reported, [2, 12, 18] although others have not found this relationship to occur [14, 15, 24] . The explanation for these divergent findings remains unclear. A recent study employing an isolated coronary artery preparation from diabetic dogs found an increased responsiveness to 9,11-methanoepoxy PGH2 [22, 23] , which is in accordance with the present finding of an increased constrictor response to this endoperoxide analogue in the coronary vessels of isolated perfused hearts from diabetic animals. Since endoperoxides and thromboxanes are thought to exert their constrictor response in vascular smooth muscle by mobilization of external calcium, the increased responsiveness to constrictor agents in vessels isolated from diabetic rats may be associated either with an increased tendency of eicosanoid constrictors to transfer calcium ions inwardly or to a generalized enhanced vascular sensitivity to calcium.
In addition to changes in vascular responsiveness to prostaglandin analogues, alterations were observed in PGI2 formation by aortic and coronary vessels of diabetic rats. In the present study, aortic vessels from diabetic animals showed a decreased release of PGI2 at 5, 7.5 and 10 min of incubation when compared with control vessels. Furthermore, formation of PGI2 by homogenates of aortic vessels from diabetic animals was reduced, suggesting that the decreased synthesis of PGI2 is not due to a compartmentalization of essential factors in prostacyclin formation within the tissue (e. g. enzymes, substrates, cofactors). These results are in agreement with other studies showing reduced PGI2 release from vessels of diabetic patients and animals [3, 19, 20, 23] . The mechanism of the reduced PGI2 release from diabetic vessels is unclear. Possible explanations include: (a) endothelial cell atrophy or damage, (b) decreased prostacyclin synthetase activity, and (c) decreased availability of substrate. In our studies, the addition of exogenous arachidonic acid (25 Ftmol/1) resulted in increased prostacyclin release in both diabetic and control rat aortae. In the presence of this exogenous arachidonic acid, there was no difference in prostacyclin release by aortic vessels from diabetic or control animals. These results tend to exclude endothelial cell loss or damage as a major mechanism, and further suggest that inadequate endogenous substrate levels or impaired substrate availability may contribute to reduced prostacyclin release. The fact that high amounts of arachidonic acid enhance prostacyclin production further suggests that the biosynthetic pathway responsible for prostacyclin generation can be acutely activated in vessels from diabetic rats. This pathway may be a site of action to consider in future treatment of vascular complications in diabetes.
In contrast to the reduced PGI2 synthesis in aortic tissue, PGI2 release was increased two-to threefold in the isolated perfused heart of diabetic rats. This unusual finding is in agreement with recent reports describing an increased PGI: release from isolated perfused hearts of acutely diabetic rats [18] and from coronary artery preparations isolated from acutely diabetic dogs [23] . The increased PGI2 formation in diabetic animals may reflect a compensatory action of the coronary vasculature to protect against noxious stimuli. In any event, increased substrate availability has been proposed as a possible mechanism for increased PGI2 production in acutely diabetic animals, since there is a large mobilization and loss of body fat during the first few days following the induction of diabetes [22] . As demonstrated in this study, however, the enhanced PGI2 release is found also in chronically diabetic animals in the presence of exogenous arachidonic acid, which suggests that mechanisms other than increased substrate availability are responsible for the elevated PGI2 production in the coronary vasculature of diabetic animals. The primary mechanism involved remains to be elucidated.
